Livzon Pharmaceutical to review Q3 2025 results at October board meeting

Livzon Pharmaceutical Group Inc. announced its Board of Directors meeting will be held on Thursday, October 23, 2025. The primary agenda for the meeting is to review and approve the unaudited quarterly results of the company and its subsidiaries for the nine months ended September 30, 2025, in addition to handling other unspecified business.

As of the announcement date, the executive directors of the company include Mr. Tang Yanggang (president) and Mr. Xu Guoxiang (vice chairman and vice president). The non-executive directors are Mr. Zhu Baoguo (chairman), Mr. Tao Desheng (vice chairman), Mr. Lin Nanqi, and Mr. Qiu Qingfeng. The independent non-executive directors are Mr. Bai Hua, Mr. Tian Qiushi, Mr. Huang Jinhua, Mr. Luo Huiyuan, and Ms. Cui Lijie.

The announcement was made from Zhuhai, China, on October 9, 2025, by Mr. Liu Ning, the company secretary, on behalf of the Board of Directors.